Brief: Northwest Biotherapeutics says registered direct offering of $12.6 mln
23/12/2015 14:00
Dec 23 (Reuters) - Northwest Biotherapeutics Inc NWBO.O : * Nw bio announces a registered direct offering of $12.6 million * Is selling an aggregate of 3.5 million shares of common stock at a purchase price of $3.60 per share Source text for Eikon urn:newsml:reuters.com:*:nPn6kHNl7 Further company coverage NWBO.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Northwest Biotherapeutics
See all newsBrief: Northwest Biotherapeutics And The UK National Health Service Blood And Transplant Announce Collaboration To Support Dcvax®-L Production
Brief: Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Brief: Northwest Biotherapeutics Provides Update On Near Term Plans For Submission Of Marketing Authorization Application
Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
Brief: Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB